The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such ...

An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer Inc. and is seeking to spur a turnaround of ...

New data from the CDC and other leading health agencies shows a number of health markers are beginning to improve in the US - ...

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance.

In the research, mice were fed a high-fat diet were injected with the compound AP39, which delivers hydrogen sulfide direct to mitochondria in cells The research concluded that the treatment ...

New-generation anti-obesity drug Wegovy, made by the same company that created Ozempic, is now available in France – but it will not be funded by the French social security system. Danish ...

Researchers have unveiled a novel approach to tackle obesity by targeting fat absorption in the small intestine. The ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.